Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
66.94 USD | -0.13% | +0.09% | -17.31% |
Apr. 23 | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
Apr. 22 | Cantor Fitzgerald Adjusts Gilead Sciences' Price Target to $75 From $78, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.31% | 83.58B | |
+25.31% | 672B | |
+25.87% | 570B | |
-5.58% | 360B | |
+15.95% | 321B | |
+8.43% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-8.93% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- SVB Securities Initiates Gilead Sciences at Market Perform With $68 Price Target